home / stock / clrb / clrb news


CLRB News and Press, Cellectar Biosciences Inc. From 12/27/20

Stock Information

Company Name: Cellectar Biosciences Inc.
Stock Symbol: CLRB
Market: NASDAQ
Website: cellectar.com

Menu

CLRB CLRB Quote CLRB Short CLRB News CLRB Articles CLRB Message Board
Get CLRB Alerts

News, Short Squeeze, Breakout and More Instantly...

CLRB - Top Penny Stocks To Watch Before 2021 If You Like Biotech Stocks

Biotech Penny Stocks To Watch With Recent Updates It’s funny to think that 2020 is almost over yet penny stocks remain a major focus for traders right now. One of the main reasons for this has been the unrelenting focus on volatility. Believe it or not, I think 2020 was p...

CLRB - WATT, MVIS, SOL and ONTX among midday movers

Gainers: Jaguar Health (JAGX) +191%.Ocugen (OCGN) +177%.Acasti Pharma (ACST) +88%.Scopus BioPharma (SCPS) +50%.Foresight Autonomous Holdings (FRSX) +35%.Onconova Therapeutics (ONTX) +32%.Evogene (EVGN) +31%.Energous Corporation (WATT) +29%.VivoPower International (VVPR) +26%.Phoenix New Media...

CLRB - Ocugen, Jaguar Health leads healthcare gainers; Cellectar Biosciences, CRH Medical among major losers

Gainers: Ocugen (OCGN) +263%, Jaguar Health (JAGX) +108%, Acasti Pharma (ACST) +61%, Scopus BioPharma (SCPS) +43%, Ekso Bionics Holdings (EKSO) +21%.Losers: Cellectar Biosciences (CLRB) -31%, CRH Medical (CRHM) -23%, CNS Pharmaceuticals (...

CLRB - Cellectar Biosciences stock slumps 35% PM, prices public offering and private placement

Cellectar Biosciences (CLRB) prices previously announced underwritten public offering of its common stock for gross proceeds of ~$24.5M at a public offering price of $1.35 per share.In a separate concurrent private placement transaction led by healthcare-focused institutional investors, compa...

CLRB - Cellectar Biosciences Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement

FLORHAM PARK, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the pricing of its previously a...

CLRB - Cellectar Bio readies stock offering

Cellectar Biosciences (CLRB) intends to offer and sell shares of its common stock in a public offering.Actual size, price or terms of the offering are not yet determined. Concurrently, the Company expects to sell common stock and convertible preferred stock at a public offering price, in a pr...

CLRB - Cellectar Biosciences Announces Proposed Underwritten Public Offering and Concurrent Private Placement

FLORHAM PARK, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that it intends to offer and se...

CLRB - 5 Biotech Penny Stocks To Watch With Upcoming Events Before 2021

Looking For Biotech Penny Stocks Right Now? One of the most active sets of penny stocks in 2020 has been biotech stocks. Aside from the obvious push from COVID-19 vaccine candidates, companies are utilizing the increased attention to build upon novel treatment pipelines. Evidenced b...

CLRB - Are These The Best Penny Stocks To Buy Now? 4 With 9%-626% Targets

Are Analysts Right About These Penny Stocks? Whether you’re day trading or investing in penny stocks , everyone wants an edge. Some go to extreme lengths to stay 1 step ahead of the retail market. Whether it’s pouring through pages of filings or actually taking a trip ...

CLRB - 5 Biotech Penny Stocks To Watch With Recent & Upcoming Events

Are These Biotech Penny Stocks On Your Radar This Week? When it comes to finding penny stocks to buy, speculation can fuel momentum. One of the top sectors that play off of this speculation well is biotech. Right now, biotech stocks are some of the hottest in the market. This is...

Previous 10 Next 10